Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-01

Clinical Trial Update: Faecal Bacteriotherapy for Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial update on faecal bacteriotherapy for ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institute for Clinical and Experimental Medicine | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED